Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

106.51
Delayed Data
As of Apr 24
 -1.32 / -1.22%
Today’s Change
96.18
Today|||52-Week Range
149.34
-10.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line656.9M144.4M399.0M443.3M
 
 
 
 
 
Depreciation46.9M160.2M386.0M487.5M
 
 
 
 
 
Total Other Cash Flow-67.3M390.2M333.0M401.2M
 
 
 
 
 
Funds From Operations482.6M1.1B1.2B1.3B
 
 
 
 
 
Funds From/For Other Operating Expenses-157.4M415.2M136.0M170.5M
 
 
 
 
 
Net Cash Flow - Operating Activities640.1M675.2M1.1B1.1B
 
 
 
 
 
 
InvestingIncrease In Investments-667.7M-534.7M-675.0M-1.7B
 
 
 
 
 
Decrease In Investments619.4M1.2B722.0M1.1B
 
 
 
 
 
Capital Expenditures-136.7M-286.3M-333.0M-357.3M
 
 
 
 
 
Net Assets From Acquisitions 0.00-3.9B0.000.00
 
 
Other Investing - Uses-507.0K---1.0M--
 
 
 
Other Investing - Sources--5.5M--100.0K
 
 
 
Net Cash Flow Investing-222.9M-3.6B-287.0M-918.3M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings0.003.7B0.000.00
 
 
Long Term Debt Reduction-55.5M-301.3M-375.0M-175.0M
 
 
 
 
 
Net Proceeds Stock Sale114.4M77.9M37.0M85.9M
 
 
 
 
 
Common Preferred Redeemed-302.6M-327.7M-430.0M-463.6M
 
 
 
 
 
Common Dividends--0.000.00----
Cash Dividends Paid - Total--0.000.00----
Other Sources - Financing251.1M26.0M0.00--
 
 
 
Other Uses - Financing261.0K144.4M68.0M43.9M
 
 
 
 
 
Net Cash Flow - Financing7.1M3.0B-836.0M-596.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-10.2M-9.0M-7.0M17.7M
 
 
 
 
 
 
Net Change In Cash424.3M75.1M-37.0M-399.3M